Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Mar 22, 2023
Finance

March 22 Quick Takes: GordonMD, Pfizer Ventures lead Flare’s $123M B round 

Plus: FDA approvals for Cidara, Incyte and updates from Karuna, Astellas, NImmune, AbbVie, Roche, Lilly
BioCentury | Dec 10, 2019
Finance

Perceptive launches $210M early-stage fund tied to Garabedian’s accelerator Xontogeny

Perceptive’s first early-stage fund will invest in fledgling companies progressing toward proof of concept
BioCentury | Apr 20, 2018
Emerging Company Profile

Clear for Landos

How Landos’ first-in-class LANCL2 agonist could improve upon existing IBD drugs
BioCentury | Sep 22, 2017
Financial News

Landos spins out of Xontogeny accelerator

BioCentury | Sep 21, 2017
Financial News

Landos spins out of Xontogeny accelerator

BioCentury | Dec 13, 2016
Distillery Therapeutics

Autoimmune disease

Items per page:
1 - 7 of 7